SANUWAVE Health, Inc. current report, Q3 FY2018

Business Context and Reporting Period

Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2018
Reporting Period: Three and six months ended June 30, 2018
Context: The Company announced financial results and provided a business update via conference call. The filing references a press release titled "SANUWAVE Health reports record second quarter revenue increase and significant milestones achieved during the quarter."

Key Financial Metrics

The provided Form 8-K text serves as a cover document referencing the results but does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. The filing states that the Company reported a "record second quarter revenue increase," but exact figures are not present in this text.

Material Changes

  • Revenue: The Company reported a record revenue increase for the second quarter ended June 30, 2018, compared to the prior comparable period.
  • Milestones: Significant business milestones were achieved during the quarter, though specific details are not listed in the filing text.

Guidance, Outlook, and Risks

Management Commentary: Management discussed financial results and business updates during a conference call on August 14, 2018. The transcript is included as Exhibit 99.2.
Guidance and Risks: The filing text does not provide specific forward-looking guidance, risk factors, contingencies, or unusual items. These details are contained within the referenced press release (Exhibit 99.1) and conference call transcript (Exhibit 99.2).

Investor Verification Checklist

  • Verify the specific revenue growth percentage and absolute dollar amounts in the referenced press release (Exhibit 99.1).
  • Review the conference call transcript (Exhibit 99.2) for details on the "significant milestones" mentioned.
  • Confirm the Company's liquidity position and cash flow status, as these figures are not included in the 8-K text.
  • Check for any updated financial guidance provided during the August 14, 2018 conference call.